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Abstract
Obstruction and perforation due to colorectal cancer represent challenging matters in terms of diagnosis, life-saving
strategies, obstruction resolution and oncologic challenge. The aims of the current paper are to update the
previous WSES guidelines for the management of large bowel perforation and obstructive left colon carcinoma
(OLCC) and to develop new guidelines on obstructive right colon carcinoma (ORCC).
Methods: The literature was extensively queried for focused publication until December 2017. Precise analysis and
grading of the literature has been performed by a working group formed by a pool of experts: the statements and
literature review were presented, discussed and voted at the Consensus Conference of the 4th Congress of the
World Society of Emergency Surgery (WSES) held in Campinas in May 2017.
Results: CT scan is the best imaging technique to evaluate large bowel obstruction and perforation. For OLCC, self-
expandable metallic stent (SEMS), when available, offers interesting advantages as compared to emergency surgery;
however, the positioning of SEMS for surgically treatable causes carries some long-term oncologic disadvantages,
which are still under analysis. In the context of emergency surgery, resection and primary anastomosis (RPA) is
preferable to Hartmann’s procedure, whenever the characteristics of the patient and the surgeon are permissive. Right-
sided loop colostomy is preferable in rectal cancer, when preoperative therapies are predicted.
With regards to the treatment of ORCC, right colectomy represents the procedure of choice; alternatives, such as
internal bypass and loop ileostomy, are of limited value.
Clinical scenarios in the case of perforation might be dramatic, especially in case of free faecal peritonitis. The
importance of an appropriate balance between life-saving surgical procedures and respect of oncologic caveats must
be stressed. In selected cases, a damage control approach may be required.
Medical treatments including appropriate fluid resuscitation, early antibiotic treatment and management of co-existing
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medical conditions according to international guidelines must be delivered to all patients at presentation.
Conclusions: The current guidelines offer an extensive overview of available evidence and a qualitative consensus
regarding management of large bowel obstruction and perforation due to colorectal cancer.
Keywords: Colon, Rectum, Cancer, Obstruction, Perforation, Emergency
Background
In 2010, the World Society of Emergency Surgery (WSES)
published the guidelines for the management of obstruct-
ive left colon cancer [1]. The 2017 guidelines represent
both an update and an implementation of the previous
edition: the management of perforation and obstruction
associated with right-sided colon cancer is also included
into the current guidelines.
The relevance of the topic is evident with the help of
the following statements:
 Colorectal cancer (CRC) is the third most
commonly diagnosed malignancy, accounting for
about 1.4 million new cases per year. It represents
the third most common cancer in men (746,000
cases, 10.0% of the total) and the second in women
(614,000 cases, 9.2% of the total) worldwide; it is the
fourth leading cause of cancer death in the world,
with almost 700,000 deaths in 2012 [2, 3].
 The incidence of CRC varies by geographic region:
in Europe, the incidence is higher than in North
America, followed by Oceania, Latin America and
Africa. However, the trend of CRC seems to vary
according to the Human Development Index (HDI),
with a variability parallel to changes in diet, smoke
attitude, activity patterns and screening programs. A
decreasing rate is reported in North America,
Oceania and Europe and in particular in the USA,
New Zealand and France; on the other side, an
increasing incidence is observed in Latin America,
Asia and Eastern Europe [3].
A word of caution must be spent with regards to the
increasing incidence of CRC in the population younger
than 50 years: this could potentially encourage an update
in screening programs [4, 5].
 Complications of large bowel diseases account for
47% of gastrointestinal emergencies [6].
 CRC presents as emergency in a wide range of patients
(from 7 to 40% of the total), but the vast majority of
reports present a figure of around 30% [6–15].
 Large bowel obstruction (LBO) represents almost
80% (15–30% of CRC) of the emergencies related to
CRC, while perforation accounts for the remaining
20% (1–10% of CRC) [7, 12, 16, 17].
 The most common location of CRC obstruction is
the sigmoid colon, with 75% of the tumours located
distal to the splenic flexure [18].
 Perforation occurs at the tumour site in almost 70%
of cases and proximal to the tumour site in around
30% of cases [6, 19, 20].
Management of obstruction and perforation of the colon
and rectum secondary to CRC is challenging in terms of
clinical severity, diagnostic and therapeutic options and
management of septic and oncologic issues.
Focused guidelines lack of evidence and consensus is
often limited to short sections within general colon and rec-
tal cancer guidelines edited by Surgical Societies [21–23].
Materials and methods: consensus conference
organisational model
In July 2016, the Scientific Board of the WSES endorsed
the President of the Society and the President of the 4th
World Congress of the WSES to prepare the Consensus
Conference on Colon Rectal Cancer Emergencies (CRCE)
focusing on obstruction and perforation.
The Presidents and the six members of the Scientific
Secretariat agreed on six key questions to develop the
topics for the current guidelines; according to the skills
(residency program, work and scientific experience), 12
international experts, affiliates of the WSES, were chosen
as Scientific Committee of the Consensus Conference.
Each question was developed by members of the Scientific
Committee in a variable number from 2 to 4 according to
the magnitude of the topic: the Scientific Secretariat mem-
bers and the Presidents supervised each group.
The documentarist of the Papa Giovanni XXIII Hos-
pital medical library, with the support of the Scientific
Secretariat, provided the electronic search in PubMed
and EMBASE databases, according to specific key words
for each questions, without time or language restrictions
(Table 1).
The additional bibliography research was developed by
each group before starting and updated to May 2017. The
research presented at the CC as “in press” has been kept
in consideration if published before the final revision of
the present guidelines. Each working group, before the
CC, developed a focused draft and a variable number of
statements along with the level of evidence (LoE) and the
grade of recommendation (GoR) for each statement. The
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2011 Oxford Classification was used to grade the LoE and
GoR (available at https://www.cebm.net/category/ebm-re-
sources/loe/).
The provisional statements and the supporting literature
were reviewed by the SS and the Presidents, discussed
with the members of each working groups by email and
call conferences and modified if necessary.
The Consensus Conference on CRCE has been held in
Campinas, Brazil, on May 18, 2017, during the 4th World
Congress of the WSES.
The designated member of each working group pre-
sented the statements to the audience, along with LoE,
GoR and the literature supporting each statement. The
audience, represented by 45 experts, voted each statement
using a red/green double face card (green, agreement; red,
disagreement). The exact agreement/disagreement ratio
was not calculated simultaneously to avoid waste of time:
for the entire vote, it ranged from 45/0 to 38/7 (18%);
despite the small percentage of disagreement, each red
card comment was discussed and a final agreement
reached among participants.
The agreement required some statement modification,
performed by the Presidents and by the Scientific Secretar-
iat; all the statements were eventually reviewed by the WSES
board and modified accordingly (Table 6 in Appendix 1).
Further literature published between May and
December 2017 was also considered. Clinicians and
surgeons must be aware that the present WSES
guidelines should be considered as an adjunctive tool
for decision and management but they are not substi-
tute of the clinical judgement for the individual
patient.
Results
The results are hereby presented separately as O (ob-
struction) and P (perforation) when required; other-
wise, the statements can be considered valid for both
conditions.
Diagnosis
Statement 1.1: The clinical presentation is variable,
except for lower rectal cancer, in which case digital
examination could be diagnostic. Laboratory tests are
not specific. Clinical evaluation and laboratory tests have
high variability and low specificity; therefore, the escal-
ation to further diagnostic tools, whenever available, is
mandatory. LoE 3, GoR B.
Obstruction
Large bowel obstruction can present acutely, with colic-like
abdominal pain, abdominal bloating and absence of bowel
movement and flatus, while vomiting is less frequent than
in small bowel obstruction, or subacutely, with gradual
development of symptoms, changes in bowel habits and re-
current left lower quadrant abdominal pain. In a series of
150 consecutive patients suffering from acute mechanical
bowel obstruction, 24% presented with large bowel obstruc-
tion. Absence of passage of flatus (90%) and/or faeces
(80.6%) and abdominal distension (65.3%) were the most
common symptoms and physical signs [24].
Abdominal examination shows tenderness, abdominal
distension and hyperactive or absent bowel sounds.
Previous complaint of bloody stools and passage of blood
per rectum, despite the absence of bowel movement, can
be associated with colon cancer. A rectal cancer may be
palpable as an intrinsic lesion [25, 26].
Laboratory tests are directed at evaluating the electro-
lyte imbalances, elevated urea nitrogen and metabolic
alkalosis that may occur as a consequence of vomiting
and dehydration.
Perforation
When perforation occurs at the tumour site, peritoneal
contamination is usually localised; at the opposite, when
perforation is located proximal to the tumour site, the fae-
cal spread results in diffuse peritonitis and septic shock.
Table 1 Questions and MeSH terms
Questions Key words
Diagnosis diagnosis, cancer, neoplasm, colon, rectum, bowel, perforation, obstruction, physical examination, radiology, laboratory,
abdominal ultrasound, CT scan, colonic enema
Perforation perforation, cancer, neoplasm, colon, rectum, bowel, tumour perforation, diastatic perforation, faecal peritonitis, treatment,
surgery, acute care surgery
Obstruction left obstruction, left colon, rectum, cancer, neoplasm, surgery, acute care surgery, stent, SEMS, Hartmann’s procedure,
colostomy, resection, anastomosis, tube decompression
Obstruction right obstruction, right colon, rectum, neoplasm, surgery, acute care surgery, stent, SEMS, loop ileostomy, intestinal bypass,
resection, anastomosis, tube decompression
Unstable patients unstable patient, haemodynamic instability, critically ill patient, sepsis, peritonitis, obstruction, cancer, neoplasm, colon,
rectum, surgery, acute care surgery, damage control, open abdomen.
Antibiotics antibiotics, therapy, prophylaxis, colon, rectum, perforation, obstruction, unstable patient, haemodynamic instability,
critically ill patient obstruction, bowel, sepsis, peritonitis, surgery, acute care surgery.
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In this setting, physical examination reveals an acutely
ill patient characterised by fever, tachypnea, tachycardia
and confusion.
The abdomen may be diffusely tender or may present
localised tenderness, guarding, or rebound tenderness.
Bowel sounds are usually absent. The toxic symptoms of
peritonitis are usually delayed, but are considered an om-
inous sign [27]. Leukocytosis and neutrophilia, elevated
amylase levels and lactic acidosis suggest perforation or
necrosis [28]. The suspicion of large bowel obstruction or
perforation is based on aspecific symptoms, signs and
laboratory findings: adjunctive diagnostic tests are
mandatory, whenever available (Fig. 1).
Statement 1.2: (a) In case of clinical suspicion of colon
obstruction, computed tomography (CT) scan achieves
diagnostic confirmation better than abdominal ultra-
sound (US), which performs better than abdominal plain
X-ray. If CT scan is not available, a water-soluble con-
trast enema is a valid alternative for identifying the site
and the nature of obstruction. (b) In case of clinical sus-
picion of perforation, abdominal CT scan, which per-
forms better than abdominal US, should achieve
diagnostic confirmation. US performs better than abdom-
inal plain X-ray. LoE 3, GoR B.
Abdominal plain X-ray and abdominal US are screen-
ing imaging tests, with the latter representing the more
performing alternative. With these results, after adequate
training, bedside abdominal ultrasound examination
could replace abdominal plain X-ray (Table 2).
As a consequence, the clinical suspicion of bowel obstruc-
tion should be, as a first step, tested by abdominal US or by
plain abdominal X-ray when the abdominal US expertise is
not available or the US machine is not promptly available.
Despite contrast enema shows acceptable sensitivity and
specificity, abdominal CT scan, with high sensitivity and
specificity, has the absolute advantage to provide the clin-
ician with an optimal grade of information, in particular
regarding the complications of cancer-related LBO.
Moreover, it is possible to stage the neoplastic disease and
to identify synchronous neoplasms (Table 2). Due to this
multifaceted profile, CT scan represents the imaging test
of choice in current clinical practice; if CT is available, the
water-soluble contrast enema can be considerate obsolete.
When the clinical scenario is suggestive of bowel perfor-
ation, abdominal US or abdominal plain X-ray should be
used as first screening imaging tests. Bedside abdominal
US, performed by a trained physician or surgeon, has
higher sensitivity and same specificity of abdominal plain
X-ray [29]; moreover, it reduces the mobilisation of a
critically-ill patient. One of the limitations of the
abdominal US and of the abdominal plain X-ray is the risk
of false negatives of pneumoperitoneum, when a small
amount of intraperitoneal free air is present, such as in
the case of early perforation at the tumour site (Table 3).
When bowel perforation is suspected, screening imaging
tests are represented by abdominal US or abdominal plain
X-ray. The literature shows that bedside abdominal US
has a higher sensitivity and same specificity with abdom-
inal plain X-ray; moreover, it allows environmental stress
reduction to an acutely ill patient [30].
Statement 1.3: In stable patients, direct visualisation of
the site of colonic obstruction should be considered when
colonoscopy is available. In this situation, biopsies should
be obtained, especially when the deployment of an endo-
scopic stent is planned. LoE 3, GoR B
The role of colonoscopy in the setting of the diagnosis
of LBO is limited; this is mainly due to its low availabil-
ity in the emergency setting. The aim of the direct visu-
alisation is to explore the various aetiologies of
obstruction. Biopsies and histologic examination of the
lesions should be performed when an emergency surgi-
cal resection has not been planned or endoscopic stent
placement can be expected [18, 21, 31].
Statement 1.4: In case of diagnosis of perforation at
abdominal US or abdominal X-ray in a stable patient,
abdominal CT scan should be considered, in order to
Fig. 1 Cumulative diagram for the three items (confirmation, cause, site of LBO) according to imaging study. US ultrasound, CT
computerized tomography
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define the cause and the site of perforation. If there are
clear signs of diffuse peritonitis, CT scan should not delay
the appropriate treatment. Early involvement of the
surgeon is required. LoE 3, GoR B
Although free air in the peritoneal cavity leads, in the
vast majority of cases, to surgical exploration, CT scan
examination is suggested if available.
In fact, in few cases of pneumoperitoneum, a conser-
vative management could be attempted, depending on
the gastrointestinal perforation site; moreover, there are
some cases of pneumoperitoneum which are unrelated
to intestinal perforation [32, 33].
Furthermore, CT scan can help the surgeon to foresee
the operative scenario, with a better prediction of the
resources needed for the intervention [34].
Despite its utility, it must be stressed that CT scan,
even when readily available, should never expose the
patient to unsafe delays in the appropriate treatment.
Statement 1.5: There is no specific data regarding
staging pathways of CRC presenting as an emergency. CT
scan performs better than US in the abdomen and should
be suggested for staging in the suspicion of cancer-related
colorectal emergencies. CT scan of the thorax is not
strictly recommended. LoE 3, GoR B
The 2017 NCCN guidelines on colon cancer recom-
mend CT scanning for staging of liver metastases from a
colorectal primary tumour, given its best accuracy among
the available preoperative tests [35].
Evidence to support the indication for routine CT of
the thorax is weak: a resolving power of 2–3 mm for
lung nodules leads to a sensitivity of 100%, but the spe-
cificity is low, with a false positive rate of 34%. On the
other side, chest X-ray has a low sensitivity (30–64%),
but has a specificity as high as 90% [36].
This data should be kept into consideration also when
approaching CRCE: if available, preoperative CT scan of
the abdomen should be obtained for staging, while X-ray
of the chest may be appropriate for staging of the chest.
As previously stated, CT scan for staging should never
expose the patient to a safety risk, in terms of time and
actions subtracted to the patient's care.
2. Management of perforation
Statement 2.1: When diffuse peritonitis occurs in
cancer-related colon perforation, the priority is the control
of the source of sepsis. Prompt combined medical treat-
ment is advised. LoE 2, GoR B
While keeping in mind the caveats of oncologic treat-
ment for patients with perforated CRC, the priority must
be directed to immediate patient safety and therefore to
treatment of the septic status and to control of the source
of sepsis (see Appendix 2).
When free peritonitis, usually related to perforation prox-
imal to tumour site, occurs, patients are at a higher risk of
development of septic shock, as compared to patients with
a contained collection, which is usually related to perfor-
ation at the tumour site for necrosis [6, 19, 20, 37–39].
In cases of contained intra-abdominal collections from
perforated CRC, the mortality rate is between 0 and 24%,
with an increase to 19–65% in the case of diffuse faecal
peritonitis: this difference reaches statistical significance.
Despite this finding, the severity of peritonitis, at multi-
variate analysis, is not an independent factor influencing
the in-hospital mortality [6, 20].
Moreover, the in-hospital mortality is related to the
site of perforation, varying from 37 to 60% for perfor-
ation at the tumour site or proximal to the tumour site,
respectively [20].
Table 2 Comparison of imaging studies for confirmation, cause and site of LBO
Confirmation of LBO obstruction Cause of LBO Site of LBO
Sensitivity Specificity Sensitivity Specificity Sensitivity Specificity
Plain X-ray 74–84% [26] 50–72% [26, 211, 212] 0 7% [212] 0 60% [212]
Abdominal US 88% [211] 76% [211] 0 23% [212] 0 70% [212]
Colonic enema 96% [26] 98% [26] 0 96% [26] 96% [26] 98% [26]
CT scan 93–96% [212, 213] 93–100% [212, 213] 0 66–87% [212, 214] 95% [213] 90–94% [29, 213]
Table 3 Comparison of imaging studies for confirmation and site of perforation
Confirmation of perforation Site of perforation
Sensitivity Specificity Sensitivity Specificity
Abdominal plain X-ray 53% [30] 53% [30] NS NS
Abdominal US 92% [30] 53% [30] NS NS
Colonic enema NS NS NS NS
CT scan 95% [29] 90% [29] NS 90% [29]
NS not stated
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The treatment of patients with septic shock due to
intra-abdominal infection (IAI) is time-dependent; the
medical treatment and the source control should be
started as soon as possible. The details of the treatment
of complicated IAI lie outside the intent of the present
study; a number of guidelines are available on this topic
[40, 41].
Statement 2.2: Oncologic resection should be performed
in order to obtain better oncologic outcomes.
– Perforation at the tumour site: formal resection with
or without anastomosis, with or without stoma.
– Perforation proximal to tumour site (diastasic):
simultaneous tumour resection and management of
proximal perforation is indicated. Depending on the
colonic wall conditions, a subtotal colectomy may be
required. LoE 3, GoR B
The surgeon should consider that only a small propor-
tion of patients undergo reversal of a terminal stoma.
In CRCE, the long-term oncologic outcome can be
influenced by an advanced disease and by the higher rate
of incomplete preoperative workup. However, in case of
perforation, the presence of undiagnosed metastases has
a small impact in the treatment strategy.
Keeping in mind that immediate patient safety takes pri-
ority, the performance of a standard oncologic resection
can lead to similar results, as compared to elective cases.
In the series of Zielinski et al., oncologic features in per-
forated CRC were obtained: patients were matched com-
paring free peritonitis versus contained collection; a third
group of CRC without perforation was used as a control
group (all groups were balanced for demographics and
tumour staging). Authors observed a progressive increase
in the lymph node harvesting rate across the three groups
(free peritonitis, contained collection and no perforation
cases); statistical significance was reached only when com-
paring all perforations versus no perforation (11 versus 16;
p < 0.001). This significance, however, was not evident
when comparing the positive nodes only. For other out-
comes, such as completeness of resection, rate of adjuvant
therapy and time to adjuvant therapy, the comparison
showed no significant difference [6].
Biondo et al., interestingly, observed similar results
when comparing patients undergoing emergency surgery
for occluded CRC to patients with perforated CRC [19].
Long-term oncologic outcomes were analysed in the
same studies: Zielinski and colleagues showed that, when
adjusted by excluding the perioperative mortality, overall
survival (OS) was similar for free faecal peritonitis, as
compared to contained collection and in all perforated
compared with non-perforated cases. At the opposite,
the inclusion of the perioperative mortality dramatically
increases the difference in terms of OS in case of free
faecal peritonitis; however, at the multivariate analysis,
perforation is not an independent factor for OS [6].
Similar results were obtained by Biondo et al. [19].
As a consequence, in case of perforation at the tumour
site:
 For right-sided perforation, a right colectomy should
be performed. In case of poor general or adverse
local conditions, a resection without anastomosis
and terminal ileostomy should be performed.
 For transverse/left-sided perforation: resection with
anastomosis, with or without ileostomy, should be
attempted. Hartmann’s procedure might be
considered, keeping in mind the low rate of stoma
reversal. In case of perforation at a distant site from
the tumour (generally the neoplasm is in the left
colon and the perforation is found in the caecum), a
subtotal colectomy should be attempted. The
literature reports a better control of postoperative
diarrhoea with resection of less than 10 cm of
terminal ileum and a distant colon remnant above
the peritoneal reflection of at least 10 cm of length
[42, 43].
The surgeon managing CRC perforation should decide
whether to perform the intestinal anastomosis or to
carry out a derivative stoma. There is no evidence of
sound quality to guide evidence-based decisions, as spe-
cific studies mostly consider heterogeneous groups of
perforated and obstructed cancer-related LBO. The rate
of anastomotic leak (AL) in right colon resections varies
from 0.5 to 4.6% in perforated emergency cases and
should be compared with 0.5–1.4% reported for elective
surgery; the AL rate after left colonic resection ranges
from 3.5 to 30% in emergency versus 5–10% in elective
cases [30, 44].
As a general rule, principles of oncologic resection
should be followed, always considering the importance of
the medical comorbidities and of the septic status on the
one side and the aim of a shortened uncomplicated post-
operative course in order to allow oncologic staging com-
pletion and the start of chemotherapy programs, on the
other side.
A word of caution should be spent on the risk of
peritoneal carcinomatosis in perforated CRC: a single
prospective series is available in the literature. All other
series included a small number of patients, with a long
data collection time and inclusion criteria, seldom expli-
cated, were heterogeneous (inclusion or exclusion of
patients with perforation proximal the tumour site etc.).
In 2013, Honoréet al. published a systematic review,
concluding that the rate of peritoneal carcinomatosis in
perforated CRC ranges between 14 and 54%,with a level
of evidence 3b to 4 [45].
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Management of obstruction: left colon (from the distal
transverse colon to the anus)
Several options to manage obstructive left colon cancer
(OLCC) are available (see Table 4 and Appendix 3).
Statement 3.1: Loop colostomy (C) versus Hartmann’s
procedure (HP)
Hartmann’s procedure should be preferred to simple
colostomy, since colostomy appears to be associated with
longer overall hospital stay and need for multiple opera-
tions, without a reduction in perioperative morbidity LoE
2, GoR B.
Loop colostomy should be reserved to unresectable tu-
mours (if SEMS is not feasible), for severely ill patients
who are too unfit for major surgical procedures or gen-
eral anaesthesia.
A stoma provides colonic decompression with min-
imal surgical trauma, reduces the risk of contamination
from an unprepared bowel and allows an intensive
resuscitation of the patient and a better staging prior to
the definitive treatment.
However, Fielding et al. [46] did not find any differences
in the mortality rate between 47 patients treated with loop
colostomy and 90 patients who received a primary
resection.
A RCT [47] between Hartmann’s procedure (63
patients) and colostomy (58 patients) found no differ-
ence in terms of mortality and morbidity rate, recur-
rence rate and cancer-specific survival between the two
surgical approaches. On the other hand, the overall
length of hospital stay was shorter in the primary resec-
tion (35 days) than in the staged resection group
(49 days) (p = 0.01).
A Cochrane systematic review [48] considered only
other four retrospective cases series and no RCT; there-
fore, a meta-analysis could not be performed.
Since then, another RCT was published [49]; the authors
found a similar impact on mortality and hospitalisation
with both surgical techniques.
Statement 3.2: Hartmann’s procedure (HP) versus re-
section and primary anastomosis (RPA)
RPA should be the preferred option for uncomplicated
malignant left-sided large bowel obstruction in absence
of other risk factors.
Patients with high surgical risk are better managed
with HP. LoE 3-GoR B.
HP remains one of the most common procedures in
emergency surgery of the left colon [50–52]. However,
the historical concept that a completely clear colon is
necessary to avoid AL [53] has been questioned by
others [54, 55], and there is now good evidence sup-
porting that the presence of faeces in the large bowel
does not influence the rate of anastomotic dehiscence,
[56, 57] nor its severity [58].
In recent years, there has been an increasing trend to-
ward a one-stage resection for left-sided obstruction, but
unfortunately, no RCTs were conducted comparing HP
and RPA; therefore, neither grade A nor B evidence are
available, and the choice generally depends on the indi-
vidual surgeon’s judgement.
The first major report regarding RPA for obstructive
cancer came from the Large Bowel Cancer Project (LBCP).
The authors reported a mortality of 35% for staged resec-
tions and of only 14% for primary resection [46].
Since then, many prospective and retrospective series
on RPA in OLCC reported rates of anastomotic dehis-
cence ranging from 2.2 to 12% [59–65]; these results are
almost comparable to the 2–8% rate after elective surgery
[56, 57, 66, 67].
Meyer et al. [51] reached different conclusions: they
compared HP and RPA performed for OLCC both with
curative and palliative intent. Despite the significantly
higher preoperative risk within the HP group, postopera-
tive mortality rate was lower as compared to the RPA
group, both for curative (7.5 versus 9.2%; p value re-
ported as not significant) and palliative procedures (33
versus 39%; p value reported as not significant). The
limit of this study was the high number of participating
institutions (309), which were also very heterogeneous in
terms of intensity of care, spanning from regional to
university hospitals.
Table 4 Treatment options for OLCC
Main options Choices among main options Ancillary manoeuvres among main option and choices
Loop colostomy (C) (bridge to resection or palliation)
Primary resection with end colostomy:
Hartmann’s procedure (HP)
Resection and primary anastomosis (RPA) Total/subtotal colectomy (TC) Intraoperative colonic irrigation (ICI)
Manual decompression (MD)
Covering stomaSegmental colectomy (SC)
Tube decompression
Endoscopic colonic stenting by self-expanding
metallic stents (SEMS)
Bridge to surgery
Palliation
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The main advantage of RPA is to avoid a second major
operation, which is associated to a morbidity rate of 20–
50% and a dehiscence rate of 2–7% [68–72].
Furthermore, it should be considered that the majority
of stomas (up to 90%) created during HP for CRC do
not get reversed, due to necessity of adjuvant treatment
and/or disease progression [62, 73].
In favour of RPA, it has also been postulated that this
choice may result in long-term survival benefits, al-
though evidence on this aspect is weak [65].
These unquestionable advantages of RPA must be
counterbalanced by the potentially catastrophic situation
resulting from AL in a fragile patient. For this reason,
many parameters, related to both the surgeon and the
patient, should be taken into account before deciding to
perform a colo-colonic or colo-rectal anastomosis [63,
64, 74]. Historically, two main elements prevent anasto-
motic dehiscence: a tension-free anastomosis and good
blood supply to the anastomotic rim; despite the single
surgeon’s experience may play a pivotal role in the evalu-
ation of these parameters, evidence exists regarding the
validity of the assessment of the anastomotic blood sup-
ply using intraoperative near-infrared indocyanine green
[75, 76]. Risk stratification is the cornerstone of patient’s
selection. The Association of Coloproctology of Great
Britain and Ireland (ACPGBI) identified four important
predictors of outcome—age, ASA grade, operative
urgency, and Dukes’ stage [64]; others showed similar
results [63, 74].
The experience and subspecialty of the surgeon also
seem to be important factors in surgical decision. It
has been demonstrated that primary anastomosis is
more likely to be performed by colorectal rather than
general surgeons, and by consultants rather than
unsupervised trainees, with lower rate of anastomotic
dehiscence and mortality [46, 74, 77–80].
Keeping in mind these considerations, HP could be
more appropriate for patients deemed to be at high
risk and when they are managed in an emergency
setting by unspecialised surgeons.
Statement 3.3: RPA: the role of diverting stoma
There is no evidence supporting that a covering
stoma can reduce the risk of anastomotic leak and its
severity. LoE 4-GoR C
Unfortunately, there are very few data and no RCT
comparing the use of diverting stoma versus no use
of diverting stoma after surgery for OLCC; therefore,
very weak recommendations can be drawn.
Kube et al. [81] analysed the results of 743 patients who
underwent emergency radical surgery for OLCC. Of these,
30% had HP, 58% RPA and 12% RPA and covering stoma.
The morbidity and hospital mortality did not differ
significantly between the groups, and the addition of
a protective stoma did not affect the rate of
anastomotic dehiscence (7 and 8% respectively), or
the rate of re-operation (5.6 versus 5.7%).
We may postulate that a protective stoma does not
reduce the rate of AL, but the rate of AL requiring
re-operation [82]. A leak originating from an intraperi-
toneal anastomosis is likely to cause diffuse peritonitis
and therefore mandates a reoperation. For this reason,
the role of diverting stoma after resection and primary
anastomosis for OLCC seems limited.
Statement 3.4: Total colectomy versus segmental
colectomy
In absence of caecal tears/perforation, evidence of
bowel ischemia or synchronous right colonic cancers,
total colectomy should not be preferred to segmental col-
ectomy, since it does not reduce morbidity and mortality
and is associated with higher rates of impaired bowel
function. LoE 2, GoR B.
Total colectomy (TC) with ileo-rectal anastomosis
was proposed as an alternative procedure to avoid a
stoma and at the same time to overcome the problems
related to a distended unprepared colon [83–85]. This
operation has an absolute indication when obstruction
has determined a right colonic ischemia, caecal tears or
perforation, or when synchronous proximal malignant
tumours are present [21].
Major disadvantages of TC are represented by a
technically challenging procedure, prolonged operative
time and poor functional results, with many patients
complaining of diarrhoea and possibly developing
electrolyte disturbances [84, 86].
A single RCT, the SCOTIA (Subtotal Colectomy
versus On-Table Irrigation and Anastomosis) trial was
published [86]; 91 patients from 12 different centres
were randomised to total/subtotal colectomy (47
patients) versus segmental colectomy with on-table
lavage (44 patients). The authors found no differences
in terms of morbidity and mortality, but significantly
worse functional results after TC.
Statement 3.5: Intraoperative colonic irrigation (ICI)
versus manual decompression (MD)
ICI and MD are associated with similar mortality/
morbidity rate. The only significant difference is that MD
is a shorter and simpler procedure. Either procedure
could be performed, depending on the experience/prefer-
ence of the surgeon. LoE 2-GoR B
There was only a RCT that compared ICI (24 patients)
with MD (25 patients) in OLCC [87]. They concluded
that MD is shorter and simpler than ICI and offers simi-
lar results in terms of mortality, morbidity and AL rates.
However, the power of this study was low.
A systematic review published in 2009, which
included the above-mentioned RCT, one prospective
comparative trial and 5 prospective descriptive case
series, concluded that, although the power of the
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studies was poor and a large-scale prospective rando-
mised trial is desirable, no statistical significance
could be shown between the two procedures [88].
Statement 3.6: RPA: the role of laparoscopy
The use of laparoscopy in the emergency treatment of
OLCC cannot be recommended and should be reserved
to selected favourable cases and in specialised centers.
LoE 4-GoR C
Traditionally, CO has been considered an absolute
contraindication to laparoscopy, because of the high-risk
patient profile and the level of operative technical diffi-
culties due to dilated and vulnerable bowel [89].
However, with the diffusion of colo-rectal laparoscopy
and increasing experience, some limited series became
available with favourable results [90, 91], but no rando-
mised trials have been produced.
Ballian et al. [92] evaluated the role of laparoscopy for
emergency restorative colectomy using the American Col-
lege of Surgeons National Surgical Quality Improvement
Program (ACS NSQIP) database. They found that less
than 10% of patients with OLCC were managed laparo-
scopically with colon resection and primary anastomosis,
with comparable rates of morbidity and mortality, but fas-
ter recovery.
A systematic review published in 2014 analysed the
results of 47 studies on laparoscopy in emergency colorec-
tal surgery, but most of them regarded acute presentation
of IBD or diverticular disease, while only a small number
presented data on OLCC [93].
Statement 3.7: Tube decompression (TD)
TD can be a valid alternative option as BTS for
high-risk OLCC. LoE 4-GoR C
Transanal TD is a minimally invasive endoscopic
procedure that may allow the decompression of an
obstructed colon in order to safely delay elective sur-
gery with RPA. Despite the appeal for this bridge to
surgery technique, unfortunately only few data is
available.
Efficacy and safety of TD have been reported [94–102],
with 80 to 100% rate of technical success and 72.5 to
100% rate of clinical success. Complications, such as
perforation, are infrequent (incidence ranging from 0 to
10%) and may be caused by the pressure of the tip of the
tube against the colonic wall.
However, there is lack of trial-based evidence to confirm
the usefulness of TD and its efficacy in terms of short-
and long-term outcomes.
Theoretically, TD has some advantages over
self-expandable metallic stent (SEMS): the colon can be
cleaned by lavage through the tube; tumour manipula-
tion is minor and costs are contained. However, there
are no randomised trials but only one retrospective
study that compared these two techniques and did not
show significant differences [103].
Despite these results appear promising, the available
level of evidence is suboptimal, and therefore, no con-
clusions can be drawn.
Statement 3.8: Palliation: SEMS versus colostomy
In facilities with capability for stent placement, SEMS
should be preferred to colostomy for palliation of OLCC
since it is associated with similar mortality/morbidity rates
and shorter hospital stay. LoE 1-GoR A
Alternative treatments to SEMS should be considered
in patients eligible to a bevacizumab-based therapy.
Involvement of the oncologist in the decision is strongly
recommended. LoE 3-GoR B
Endoscopic stent placement was initially introduced in
the palliative treatment of obstructive rectal [104] or
recto-sigmoid cancer [105].
The development of SEMS, which can be intro-
duced through a colonoscope, allowed to extend their
use to a range of scenarios of CO [106, 107], not only
with palliative intent to avoid a stoma, but also with
the aim of transforming an emergency surgical oper-
ation into an elective procedure, and od reducing
morbidity, mortality and stoma rate [108].
Several RCTs, case-matched studies and retrospective
series have been published, but results are controversial.
We found five RCT comparing colostomy versus
SEMS for palliation of malignant CO [109–112]; one of
them was an update of a previous RCT [113].
Xinopoulos et al. [109] randomised 30 patients. A
stent was successfully placed in 14/15 (93.3%) rando-
mised to stenting, and CO was permanently resolved in
eight of them (57%). There was no mortality related to
the procedure in both groups. Mean survival was
21.4 months in SEMS group and 20.9 months in C
group. Mean hospital stay was significantly higher in C
group, and costs were comparable. The authors con-
cluded that SEMS placement represents a good
alternative to colostomy, providing a better quality of life
for the patient, without the psychological repercussions
of a colostomy, and it appears to be cost-effective.
Fiori et al. [110] randomised 22 patients: in both
groups, the mortality was 0% and the morbidity was
similar. SEMS group had shorter time to oral intake,
restoration of bowel function, and hospital stay.
Some years later, the same group published the
long-term results [113]: mean survival was 297 days
(125–612) with SEMS and 280 days (135–591) in pa-
tients with stomas (p = n.s.). There was no mortality re-
lated to the procedures. Patients with stomas found
them unacceptable, and the same feelings were present
in their family members. On the contrary, none of the
patients with stents or their family members reported
any inconveniences related to the procedure.
The Dutch Stent-in I multicenter RCT [111] was
terminated prematurely after enrolling 21 patients; the
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decision was taken after the incidence of four
stent-related perforations among 10 patients enrolled for
SEMS (in particular occurring12, 12, 44 and 106 days
after stent placement), resulting in three fatal events.
No clear explanation for such a high perforation rate
was retrieved; the authors suggested that changes made
in the design of the stents (WallFlex, Boston Scientific
Natick, MA), which have a larger diameter of the
proximal end (30 mm) and are made of braided nit-
inol instead of stainless steel, might have had a role
in the aetiology of the perforation. However, other
subsequent series in which the Wallflex stent was
used reported a perforation rate of around 5% [114–116],
which is in line with commonly observed figures with
other SEMS [116].
A more recent RCT [112] enrolled 26 patients in the
SEMS group and 26 in the surgery group, with the pri-
mary aim to assess the quality of life through a validated
questionnaire. Stent insertion was successful in 19 cases
(73%), while the remaining patients required a stoma.
There were no stent-related perforations. The SEMS
group had significantly reduced procedure time (p =
0.014) and post-procedure stay (p = 0.027). Thirty-day
mortality was 8% in the SEMS group and 15% in the
surgery group (p = 0.668). There was no difference in
median survival (5.2 versus 5.5 months), but the surgery
group had significantly reduced quality of life.
Several meta-analyses [117–120], pooling data from
RCT and from prospective non-randomised or retro-
spective studies, showed results in favour of stent
placement.
According to the available RCTs [109, 112, 113],
palliation with the use of SEMS could affect the OS
indirectly, by increasing the risk of local complications,
such as tumour site perforation, and therefore requiring
the interruption of chemotherapy [118, 119].
A correlation between chemotherapy with bevacizumab
and stent-related perforation has been noticed [116, 121].
A recent meta-analysis, including 4086 patients
from 86 studies, confirmed an increased risk of
perforation in patients with bevacizumab treatment,
as compared to absence of concomitant chemotherapy
(12.5 versus 9.0%) [122].
For this specific reason, the recently published
European Society of Gastrointestinal Endoscopy (ESGE)
Clinical Guidelines do not recommend the use of SEMS
in patients who are being treated with or are expected to
be commenced on antiangiogenic drugs [123].
Statement 3.9: Bridge to surgery: SEMS and planned
surgery versus emergency surgery.
SEMS as bridge to elective surgery offers a better
short-term outcome than direct emergency surgery. The
complications are comparable, but the stoma rate is
significantly smaller. LoE 1-GoR A
Long-term outcomes appear comparable, but evidence
remains suboptimal; further studies are necessary.
For these reasons, SEMS as BTS cannot be considered
the treatment of choice in the management of OLCC,
whilst it may represent a valid option in selected cases
and in tertiary referral hospitals. LoE 1-GoR B
SEMS as BTS allows timely resolution of the obstruc-
tion before definitive surgical treatment, giving the pos-
sibility of an elective surgical procedure.
For this reason, soon after the introduction of the new
devices [105, 124], BTS with SEMS has been considered
a pivotal change in the management of colonic obstruc-
tion [106] and has been rapidly implemented in clinical
practice, although solid scientific evidences were still
missing.
In 2012, Zhang et al. [125] performed a meta-analysis
of eight studies, including six retrospective studies.
Pooled data showed impressive results in favour of stent
placement.
These extremely favourable results, however, were not
confirmed by other studies, which reported a worrisome
trend towards a stent-driven enhanced risk of oncologic
recurrence [126–128].
When adjunctive results from randomised controlled
trials became available, the overall efficacy of BTS with
SEMS appeared to be less definite than previously
reported.
Considering a total of seven trials [111, 129–134],
three were prematurely terminated for the following
reasons: very high morbidity rate in the SEMS BTS
group [111], very high morbidity rate in the ES
group[130] and high technical failure rate with SEMS
[131], respectively.
Summarising the results of these trials, the following
main findings arise.
Firstly, the rate of clinical success, which was
originally reported to be over 90%, dropped to a
mean of around 70%. Secondly, short-term results
(in particular postoperative morbidity and mortality,
length of hospital stay) appeared comparable be-
tween ES and BTS with SEMS. This was also con-
firmed by the most recently published RCT [134].
The trial was designed to recognise a 20% decrease
in morbidity in the stent group as compared to the
ES group, but in fact, complications occurred in
51.8% of SEMS group patients and 57.6% of direct
surgery group (p = 0.5).
On the other hand, all the RCTs have shown that the
use of SEMS is related to a reduction in the rate of
stomas.
Moreover, the use of SEMS increments the odds of
laparoscopic resection. The so-called endo-laparoscopic
approach consists in endoscopic stent followed by
laparoscopic elective surgery [129, 135, 136].
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In the RCT by Cheung et al. [129], all patients under-
going direct surgery had an open approach, while 60% of
patients in the SEMS group were managed
laparoscopically.
All these considerations have been confirmed by compre-
hensive data from different meta-analyses [137–143] it can
therefore be affirmed that SEMS as BTS provides better
short-term outcomes than direct ES.
The oncologic issues related to this approach remain
uncertain, and this represents a relevant field of future
research.
Analysis of available data from RCT considering
long-term outcomes [130, 133, 134, 144, 145] does not
show significant harmful effects in OS with SEMS use;
however, three of them [130, 133, 145] have reported a
tendency towards a diminished disease-free survival
(DFS). In particular, Alcantara et al. [130]reported a rate
of recurrence as high as 53.3% (8/15) after SEMS versus
15.4% (2/13) after ES.
Moreover, a recent case-control study suggested that
SEMS placement might have a critical negative impact
on the tumour anatomical site; the authors noticed a sig-
nificantly higher percentage of tumour ulceration, peri-
neural invasion and lymph node invasion in the SEMS
group as compared to the surgery-only group [126].
The main problem related to a potential augmented
risk of recurrence after SEMS is the risk of perfor-
ation, which is reported in up to 13% of cases. In
addition, Pirlet et al. described a peculiar analysis on
postoperative pathology, showing that an undetected
perforation was present in almost 27% of SEMS
[131]. Risk of perforation constitutes a major concern,
as underlined by a post hoc analysis of one RCT, in
which the 4-year DFS rate was 0% in patients with a
stent-related perforation, versus 45% in patients with-
out perforation [145].
Although worrisome to a certain extent, these results
come from studies with small number of patients and
with an overall short follow-up time to guide definitive
conclusions.
Matsuda et al. performed a meta-analysis to specific-
ally investigate the long-term outcomes of SEMS [142]:
11 studies were included, with a total of 1136 patients,
but only two of them were RCT, while two were pro-
spective series and seven retrospective.
OS was reported in all studies (3-year OS in 3 of
them), while DFS and recurrence in six and eight
studies, respectively. Pooled data showed no significant
difference between SEMS as a BTS and ES groups
neither in OS (RR = 0.95; 95% CI 0.75–1.21; p = 0.66),
nor in DFS (RR = 1.06; 95% CI = 0.91–1.24; p = 0.43) and
recurrence rate (RR = 1.13; 95% CI 0.82–1.54; p = 0.46).
Similar results were presented in the meta-analysis
from Ceresoli et al. [146]. Seventeen studies (5 RCTs, 3
prospective and 9 retrospective comparative cohort
studies), for a total of 1333 patients, were included in
the analysis. No significant differences were noticed in
recurrence rate (RR = 1.11 95% CI 0.84–1.47, p = 0.47),
3-year mortality (RR = 0.90 95% CI 0.73–1.12, p = 0.34)
and 5-year mortality (RR = 1.00 95% CI 0.82–1.22, p =
0.99). No differences were found among randomised and
observational studies.
As stated by the authors, both these meta-analyses
have a great limitation related to the quality of the
considered studies: none of the included studies was
designed for long-term follow-up, median follow-up
times were generally short and heterogeneous and
survival rates were estimated with the Kaplan–Meier
method rather than with observed events.
For these reasons, although encouraging, these
results must be considered with extreme caution. A
“non-inferiority” RCT with survival as primary end
point would be the appropriate method to correctly inves-
tigate long-term outcomes after SEMS as BTS versus ES.
Statement 3.10: Extraperitoneal rectal cancer.
Locally advanced rectal cancers are better treated with
a multimodal approach including neoadjuvant chemora-
diotherapy. LoE 1-GoR A
In case of acute obstruction, resection of the primary
tumour should be avoided and a stoma should be
fashioned, in order to permit a correct staging and a
more appropriate oncologic treatment.
Transverse colostomy seems to be the best option,
but other modalities can be considered. SEMS is not
indicated.
Extraperitoneal rectal cancers have particular features,
which deeply influence the management of obstructive
disease.
It has to be considered that a rectal cancer producing
an obstruction invariably represents a locally advanced
disease. For this reason, if curative resection is judged to
be possible, elective surgery should be preceded by
neoadjuvant chemotherapeutic treatment [147–150].
The direct consequence of this consideration is that, in
case of obstructive emergency, the surgical procedure of
choice has to be restricted to techniques aiming to solve
the obstruction and to permit a timely initiation of
multimodal therapies. Furthermore, the surgical proced-
ure should provide a long-term solution, allowing to
conduct the patient through the entire duration of neo-
adjuvant treatment, until the execution of definitive sur-
gery, and avoiding interferences with the therapeutic
schedules and final oncologic result.
– Decompressive stoma versus SEMS
No comparative studies between endoscopic stenting
and faecal diversion are available.
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However, use of SEMS in low rectal cancer has been
linked to chronic pain and tenesmus [102] and a conse-
quential worsening of quality of life. Radiation and
chemotherapy, determining tumour necrosis and shrink-
age, may favour the development of complications such
as migration and perforation that might compromise the
final oncologic results.
Moreover, it should be considered that a stoma will be
fashioned in any case at the time of surgical resection,
either in the case of abdominal-perineal resection or in
the case of low anterior resection, where a diverting
temporary stoma is highly recommended [151–153].
All these being considered, it is always preferable to
manage rectal obstruction with a stoma; the surgeon
should plan the future surgical resection and choose the
stoma type and location accordingly.
– Loop ileostomy versus loop colostomy versus end
colostomy
In essence, and in an ideal situation, the type and loca-
tion of the emergency stomas should correspond to the
type and location of future diverting or definitive stoma.
Previous studies [151, 154, 155] and a recent
meta-analysis [156] of trials comparing loop ileostomy
versus loop colostomy after elective anterior resection
showed better results after loop ileostomy.
Despite this, in case of an emergency rectal obstruc-
tion and a planned future anastomosis, a loop ileostomy
is a viable option only if the obstruction is incomplete or
the ileocaecal valve is patent; otherwise, colonic disten-
sion would not be solved. In presence of a complete ob-
struction and a competent ileocaecal valve, a colostomy
is mandatory. Scientific evidence to guide the choice of
type a location of the emergency colostomy is limited.
As stated above, the choice of type (end or loop) and
site (transverse versus sigmoid colon) of colostomy
should be tailored on the individual patient considering
the planned definitive treatment.
Limited to patients at high risk for general anaesthesia,
a loop left side colostomy could be fashioned under local
anaesthesia and intravenous sedation via left side skin
incision (the so-called trephine stoma) [157].
A widely used practical approach consists in a
right-sided loop transverse colostomy. This is preferred
over a sigmoid colostomy because it can be left in place to
protect the anastomosis after the planned surgical resec-
tion, it is easier to be fashioned due to the mobility of the
transverse colon, it avoids the risk of damage to the mar-
ginal arcade and it does not alter the left abdominal region
in case a permanent end colostomy becomes necessary at
the time of definitive surgical resection. When an
abdominal-perineal resection is predictable, an end sig-
moid colostomy could be a valid alternative [158].
Management of obstruction: right colon
Different surgical and non-surgical procedures could be
offered in the case of obstructive right colon cancer
(ORCC) (Table 5); however, right colectomy with anasto-
mosis has been considered safe, and the literature is
poor or absent in comparing theoretical options.
Statement 4.1.
In case of right-sided colon cancer causing acute ob-
struction, right colectomy with primary anastomosis is
the preferred option. A terminal ileostomy associated
with colonic fistula represents a valid alternative if a pri-
mary anastomosis is considered unsafe. LoE 2-GOR B
The literature regarding ORCC is definitely less
extensive than for OLCC, and this may be related to
favourable anatomical reasons and limitation of
alternatives to surgery, which lead to the predominance
of RC with primary anastomosis as the treatment of
choice. Several anatomical reasons can explain this
phenomenon: firstly, the hepatic flexure is easier to mo-
bilise as compared to the splenic flexure; secondly, the
mobility of the small bowel allows the surgeon to per-
form the ileo-colic anastomosis without adjunctive sur-
gical manoeuvres; thirdly, the ileo-colic anastomosis
benefits from an optimal blood supply, as compared to
some critical zones of the left colon and rectum, whose
blood supply is dependent on the patency of the mar-
ginal arcade and the hypogastric vessels. Segmental
right colon resection is extremely rare, due to the re-
duced length of the right colon and to the common
compromise of the caecum [102].
Ileostomy creation should be balanced with the risk
of electrolyte imbalance; moreover, alternatives to sur-
gery are scarce and this is related to the considerable
technical difficulty of performing operative manoeu-
vres, stenting or tube decompression, once reached
the right colon.
For these reasons, RC with primary ileo-colic anastomosis
reprsents the option of choice in ORCC, despite the fact that
patients are usually older and with a more advanced locore-
gional disease than patients with OLCC [159].
Table 5 Treatment option for ORCC
Main options Choices among
main options
Resection and anastomosis
Resection and anastomosis with
proximal stoma creation
Resection and stoma creation
Stoma creation
Intestinal internal bypass
Endoscopic stent placement Palliative/definitive
Bridge to surgery
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As previously mentioned, results from the literature
are often mixed inside the broader class of colon emer-
gencies. The rate of AL in the emergency RC is consid-
ered to be acceptable, especially when compared to left
colon resection with primary anastomosis and to elective
cases. However, retrospective studies reached heteroge-
neous results: Lee et al. reported no differences in the
mortality or leak rate between patients with right-sided
and left-sided lesions (mortality: 7.3 versus 8.9%; leakage:
5.2 versus 6.9%) [160, 161]; furthermore, in other re-
ports, the AL rate in RC ranges from 0.5 to 4.6% in per-
forated emergency cases and it should be compared to
0.5–1.4% reported for elective surgery. The interpret-
ation of the comparison of AL risk between ORCC and
OLCC may be cryptic: the high heterogeneity of results
in several studies, in which the AL rates range for OLCC
from 3.5 to 30% for emergency cases and from 5 to 10%
for elective cases, underlines this issue [27, 30, 44, 162].
No relevant reports exist comparing the AL rate, the
overall complications and the surgery-related mortality
between RC and ileo-colic anastomosis with or without
proximal loop ileostomy.
Statement 4.2: For unresectable right-sided colon can-
cer, a side-to-side anastomosis between the terminal
ileum and the transverse colon (the internal bypass) can
be performed; alternatively, a loop ileostomy can be fash-
ioned. Decompressive caecostomy should be abandoned.
LoE 2-GOR B
No relevant studies compare the possible options
to manage ORCC with unresectable right colon can-
cer: internal bypass should be preferred to loop ileos-
tomy. Surgical caecostomy should be abandoned for
the high rate of malfunction and complications: the
role of caecostomy could be reserved, via percutan-
eous technique, to an extremely small group of fra-
gile patients [23, 163–167]; the use of covered
expandable stent over previous malfunctioning percu-
taneous catheter has been reported [168].
Statement 4.3:
SEMS as bridge to elective surgery for ORCC is not
recommended. It may represent an option in high-risk
patients. LoE 2-GOR B
We already fully analysed SEMS as BTS in the OLCC
section.
The experience for ORCC especially looks into feasi-
bility and safety. In a recent multicenter retrospective
study [169], the most appropriate treatment approach
for patients with ORCC was evaluated, by comparing
short-term postoperative outcomes and long-term
oncologic outcomes after ES (emergency surgery), and
BTS short-term and long-term outcomes in the BTS
group were not inferior to those in the ES group. Right
colon stenting is considered technically challenging and
future comparative studies are needed for the
development of an evidence-based recommendation for
clinical decision-making [170].
Statement 4.4:
In a palliative setting, SEMS can be an alternative to
emergency surgery (ES) for obstruction due to right colon
cancer. LoE 3, GOR B
The use of stents in patients with incurable
large-bowel obstruction presents a number of advan-
tages and some benefits in terms of quality of life, such
as faster return to oral diet, decreased stoma rates and
reduced post-procedure stay [112].
Shim et al. evaluated the use of a new self-expanding
through-the-scope (TTS) double colonic stent in the
palliative management of patients with inoperable
proximal malignant CO. He concluded that placement
of these new self-expanding through-the-scope double
colonic stents for the management of inoperable
proximal malignant CO is a feasible, effective, and safe
form of palliative treatment for the prevention of stent
migration and tumour ingrowth [171].
Unstable patients
Statement 5.1: A patient with perforation/obstruction
due to colorectal cancer should be considered unstable
and therefore amenable for damage control treatment, if
at least one of the following items is present:
 pH < 7.2
 Core temperature < 35 °C
 BE < − 8
 Laboratory/clinical evidence of coagulopathy
 Any signs of sepsis/septic shock, including the
necessity of inotropic support
LoE 2-GoR C
Obstruction or perforation for CRC could lead to
instability of the clinical conditions: some reasons can
be recognised in fluid and electrolyte imbalance, bac-
terial overgrowth with translocation across the intes-
tinal wall, peritonitis and pre-existing comorbidities.
When facing this scenario, the emergency physician,
the surgeon, and the anesthesiologist should keep in
mind the appropriateness of the damage control
philosophy. Correct patient selection is crucial to
maximise the benefit of damage control surgery
(DCS), avoiding at the same time its overuse. Sub-
optimal evidence is available for non-trauma patients;
however, as in trauma setting, the clinical picture
may be represented by a mix of patient's factors (co-
morbidities, medical therapies), physiologic parameters
(hypothermia, acidosis, coagulopathy, early organ
dysfunction) and treatment/iatrogenic factors (magni-
tude and quality of resuscitation, time spent in sur-
gery); when these items are present simultaneously,
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they could depict a patient with a severe physiological
derangement and thus an “unstable patient” in the setting
of non-traumatic acute care surgery [172–174].
A new definition of septic shock has been recently
proposed [175], as a persisting hypotension requiring
vasopressors to maintain MAP over 65 and a persistent
lactate level > 2 despite adequate volume resuscitation.
Several scores have been developed: the APACHE score
is validated for use within an ICU setting [176], the
MEDS allows to stratify septic patients presenting to the
ED [177], the SOFA score allows a calculation of both
the number and the severity of organ dysfunctions [178],
PIRO is a staging system [179] and the quick SOFA
(qSOFA) is validated to identify adult patient with sus-
pected infection who are likely to have poor outcomes
[180]. WSES Sepsis Severity Score [181] has been
recently validated as a practical clinical score for patients
having complicated intra-abdominal infections. A score
of 5.5 is predictive of mortality with a sensitivity of
89.2% and a specificity of 83.5% [181]. Each of these
scores can be successfully applied, depending on the ex-
perience and preference of the clinician involved: the
adoption of an institutional score, among the validated
ones, should be encouraged in order to allow early rec-
ognition of unstable patients.
Statement 5.2: Damage control should be started as
soon as possible, in rapid sequence after resuscitation.
LoE 2-GoR C
The damage control (DC) concept has been extended
from trauma surgery to non-trauma surgical emergen-
cies taking into account that, despite different aetiol-
ogies, the physiological derangements experienced by
the patient are comparable. Often, in emergency general
surgery, the physiologic exhaustion is driven by sepsis or
septic shock, as in perforated patients or in patients with a
closed loop colonic obstruction induced by cancer deter-
mining a bacterial overgrowth in the obstructed segment,
with mucosal barrier breakdown and subsequent bacterial
translocation. In a retrospective analysis on 291
non-trauma patients, Person et al. [172] demonstrated
that peritonitis was the most common indication for
abbreviated laparotomy in accordance to DC philosophy
and that 29% of subjects who underwent DC was unstable
on admission to the emergency department.
The key in the preoperative phase is to correctly identify
patients who can benefit from DC and thus to consider
early and expedite surgery.
Some trigger points to dictate DC in emergency
general surgery may be borrowed from the trauma
setting, such as hypothermia (core temperature below
35 °C), metabolic acidosis (pH < 7.2; BD > 8) and clinical
or laboratory evidence of coagulopathy [173]. In a recent
retrospective review of non-trauma emergencies, Becher
et al. [174] confirmed that the aforementioned
conditions, in association with signs of sepsis or septic
shock, age ≥ 70 years and multiple comorbidities identify
a profile of decompensated patient who benefits from
the DC approach. This evidence supports previous re-
sults, published by Subramanian et al. [182], which dem-
onstrated that DC is safe and effective if applied in
elderly non-trauma patients with diminished physio-
logical reserve due to intra-abdominal catastrophes.
Differently from a trauma setting, the application of
DC in non-trauma surgical emergency requires an initial
period of resuscitation, before surgical intervention, in
order to prevent haemodynamic instability on induction
of anaesthesia. Few hours are necessary to re-establish
adequate—and not necessarily optimal—organ perfusion
and to start broad-spectrum antibiotic therapy [183].
Azuhata and coworkers [184], in a prospective
observational study, demonstrated that the time from
admission to initiation of surgery for source control
is a critical determinant of 60-day survival in patient
with GI perforation with associated septic shock,
showing a survival rate of 0% when time to initiation
of surgery was greater than 6 h.
Trying to achieve the aims of central venous pres-
sure (CVP) of 8–12 mmHg, mean arterial pressure
(MAP) ≥ 65 mmHg and central venous oxygen satur-
ation (ScvO2) ≥ 70% within 6 h from the admission,
the resuscitation phase should utilise goal-directed
methods to guide treatments [185–187].
In addition to volume resuscitation, vasoactive
medications may be required, being noradrenaline
the first-line agents and adrenaline the second-line
agent, while the use of dopamine should be re-
stricted. The administration of solutions containing
bicarbonate is not recommended to correct
hypoperfusion-induced lactic acidosis, unless pH < 7.15.
The alkalinizing agents may be needed in patients with se-
vere acidosis (pH < 7.15) secondary to catecholamine re-
ceptor resistance-induced hypotension [183].
Once in the operating theatre, the aim of DC is to
obtain source control, while the anatomical recon-
struction and abdominal closure must be considered
as secondary goals, to be deferred to a secondary pro-
cedure after physiological normalization. The precise
technical procedure used to achieve source control of
sepsis will vary depending on the local situation, the
pathology encountered and the degree of physiological
derangement.
Statement 5.3: If the patient is unstable, definitive
treatment can be delayed. LoE 2-GoR C
Right-sided obstruction
Right colectomy with terminal ileostomy should be con-
sidered the procedure of choice.
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Severely unstable patients should be treated with a
loop ileostomy.
Right-sided perforation
Right colectomy with terminal ileostomy should be
considered the procedure of choice.
If an open abdomen has to be considered, the stoma
creation should be delayed.
Right colectomy with ileo-colic anastomosis could be
performed if no significant increase in operative time is
required and good bowel vascularisation is present and
expected in the perioperative time.
Left-sided obstruction
Hartmann’s procedure should be considered the procedure
of choice. Severe unstable patients should be treated with a
loop transverse colostomy.
Left-sided perforation
Hartmann’s procedure should be considered the procedure
of choice. If an open abdomen has to be considered, the
stoma creation should be delayed.
For patient presenting acutely, the prognosis is poorer
as compared to patients presenting under elective ad-
mission. Emergency patients are older and have more
advanced tumours. Colon obstruction causes volume de-
pletion and electrolyte disorders, while perforation may
induce generalized peritonitis. These coexisting factors
may lead to patient instability, represented by metabolic
impairment, coagulopathy and signs of sepsis/septic
shock. All these factors contribute to the alteration of
the upstream of the intestinal wall that explain the high
risk of AL in the emergency setting, ranging from 4 to
13% [30, 161].
Literature data regarding outcomes after emergency
abdominal surgery in patients with advanced cancer
suggests that patients experience a high burden of
complications and high postoperative mortality after
these interventions [188, 189].
As a general principle, all efforts should be made to
resect the tumour at the index operation, but this
concept has to be balanced with caveats of Damage
Control Surgey: exhausted patients should undergo only
the procedures they can tolerate, and usually this corre-
sponds to technically easy and rapidly performed inter-
ventions, representing life-saving procedures.
Therefore, surgical options for complicated colorectal
cancer depend primarily on the location of the tumour,
comorbidities of the patient and degree of their clinical
status derangement at presentation.
For right-sided lesions, a definitive treatment RC
and ileocolic anastomosis can be considered, on the
basis of a non-significant increase in operative time
as compared to staged procedures; however, surgeon
should remember that the AL rate and the mortality
for resection in emergency is higher than in elective
cases (0.5–4.6 versus 0.5–1.4%; 7 versus 5.3%): al-
though no specific data is available, a higher rate of
AL is reasonably expected in the critical scenarios.
If the clinical condition suggests to avoid the creation of
an anastomosis, a terminal ileostomy is recommended.
The transverse colon can be stapled or a mucous fistula
can be occasionally created.
If an open abdomen (OA) has to be considered, stoma
creation should be avoided and the bowel should be left
stapled inside the abdominal cavity.
Loop ileostomy should be reserved for obstruction
when the tumour is not easily resectable or in case a
very abbreviated laparotomy is required. For
left-sided lesions in unstable patients, a single-stage
procedure represents a time-consuming intervention,
at high risk of AL, due to faecal loading and
impaired microcirculation induced by sepsis and by
the premorbid status of the patient.
Effectiveness of staged procedures (two- or three-step)
have been compared in recently published guidelines [1].
In an emergency setting, HP seems suitable for patients
who are too unwell to tolerate time-consuming proce-
dures, such as an anastomosis. In fact, HP is a rapid
intervention, it minimises surgical trauma it achieves
cancer resection, and it eliminates the risk of anasto-
motic failure. If compared with loop colostomy, HP
appears to be associated with shorter overall hospital
stay, while perioperative morbidity appears to be the
same. Loop colostomy should be reserved for unre-
sectable disease or if neoadjuvant therapy is be
planned.
Statement 5.4: In patient with perforation/obstruction
due to colorectal lesions, open abdomen (OA) should be
considered if abdominal compartment syndrome is
expected; bowel viability should be reassessed after
resection. LoE 2-GoRC
There is no clear indication to OA in patients with
peritonitis. LoE 1-GoR B
OA should be closed within 7 days. LoE 1-GoR B
The OA is defined as the intentional creation of a con-
trolled laparostomy, by leaving the fascial edges of the
abdominal wall unapproximated. When used appropri-
ately, this approach is useful in the management of pa-
tients at risk of development of abdominal compartment
syndrome, or in case the viability of the resected bowel
must be reassessed, after an abbreviated laparotomy, be-
fore performing an anastomosis. On the contrary, when
misused, OA may potentially expose the patient to ser-
ious complications, among which the onset of
entero-atmospheric fistula is the most worrisome. The
inability to re-approximate fascial edges is another draw-
back of prolonged OA.
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In a 1-year series of non-trauma OA described by
Bruns et al. [190], the most common preoperative
indications for index laparotomy leading to OA were
perforated viscus and/or the presence of extra luminal
gas on abdominal imaging. Fifty-eight patients received
bowel resection at initial operation, and 86% of them
were left with intestinal discontinuity at the index
operation. DC surgery mandated OA in 37% of cases,
while the need for a second look was the indication in
27%; the excessive contamination represented the indica-
tion for OA only in 10% of patients. The use of OA in
the management of patients with peritonitis is still
controversial. Several authors [191, 192] reported no sig-
nificant differences in morbidity and mortality between
on-demand re-laparotomy and planned re-laparotomy
groups but showed that on-demand group had shorter
ICU and hospital stay. Therefore, peritoneal contamin-
ation per se does not represent a strict indication to OA.
Aggressive source control followed by abdomen closure
should be attempted, and on-demand re-laparotomy
should be used instead [193].
In cases when planned re-laparotomy represents a
necessity, this should be performed 24–48 h after the
initial operation. An abdominal exploration delayed over
this period increases the risk of iatrogenic enteric injury,
related to intraperitoneal adhesions. The goal to be
achieved after OA is the early and definitive closure of
the abdominal wall, in order to reduce complications
associated to OA. In a systematic review [194], it has
been demonstrated that early fascial closure, within 4–
7 days of the initial laparotomy, compared to delayed
closure was associated with reduced mortality (12.3
versus 24.8%, RR 0.53, p < .0001) and complications (RR
0.68, p < .0001). In a retrospective review of 42
non-trauma patients, Khan et al. [195]achieved fascial
closure within 7 days in 57% of patients, while observing
the onset of entero-atmospheric fistula in 4 of 18
patients of the delayed closure group.
Statement 5.5: A close intraoperative communication
between surgeon and anesthesiologist is essential to assess
the effectiveness of resuscitation, in order to decide the
best treatment option. LoE 2-GoR C
A uniform approach for critically ill non-trauma
patients is crucial to achieve satisfactory outcomes. In
terms of decision-making, it is vital to recognise and
solve pitfalls in DC or in clinical decision-making.
Effective communication and the expression of non-
technical skills among anesthesiologists, nurses and
surgeons are essential to manage this typology of pa-
tients [196]. It has been demonstrated that failure to
communicate critical information in the operating
room occurs in approximately 30% of team exchanges
[197] and this could lead to inefficiency, emotional ten-
sion, delays, resource waste, patient inconvenience, and
procedural error, all of which can be detrimental. Simi-
larly, failure to communicate critical information by the
anesthesiologist during non-trauma resuscitation of the
non-trauma critically ill patient, such as the impairment
of metabolic parameters or their improvement achieved
by goal-directed resuscitation strategy, may leave the sur-
geon unaware of the degree of the patient physiologic ex-
haustion, leading him/her towards wrong surgical
decisions. Effective and prompt communication allow the
anesthesiologist and the surgeon to recognise potential
issues or dangerous circumstances and to adjust their
strategies accordingly [198], considering an early DC
approach during the multi-faced management of critically
ill surgical patients.
Antibiotic therapy
Statement 6.1: In patients with colorectal carcinoma
obstruction and no systemic signs of infection, anti-
biotic prophylaxis mainly targeting Gram-negative
bacilli and anaerobic bacteria is recommended, be-
cause of the potential ongoing bacterial translocation.
LoE 1, GoR A
To establish the effectiveness of antimicrobial prophy-
laxis for the prevention of surgical wound infection in
patients undergoing colorectal surgery, a Cochrane
review was published in 2014 including 260 trials and 68
different antibiotics [199].
The review found high-quality evidence, showing that
prophylaxis with antibiotics covering aerobic and anaer-
obic bacteria prior to elective colorectal surgery reduces
the risk of surgical wound infection.
Generally, patients with intestinal obstruction with no
systemic signs of infections present a risk of surgical site
infections similar to patients undergoing elective surgery;
in general, antibiotic prophylaxis is sufficient.
A dense population of microorganisms, referred to as
the bacterial flora, colonizes the human gastrointestinal
tract. Although the gut provides a functional barrier
between these organisms and the host, bacterial trans-
location is a possible event.
Gut translocation of bacteria is defined as the passage
of gastrointestinal microflora across the lamina propria
to local mesenteric lymph nodes and from there to
extranodal sites [200].
Major conditions can contribute to bacterial transloca-
tion including a breakdown of the intestinal barrier, an
impairment of host immune defense and a loss of the
colonisation resistance with bacterial overgrowth in the
intestinal tract [201].
Several studies support the concept considering the
gut as the source of septic complications; in this sense,
bacterial translocation may be an important intermedi-
ary mechanism in the development of sepsis [202].
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When the mucosa is injured and the intestinal barrier
is compromised, a translocation of intestinal microor-
ganisms can occur.
Obstruction cause mucosal injury with a subsequent
increase of mucosal permeability and thus bacterial
translocation [203, 204].
Statement 6.2: Prophylactic antibiotics should be
discontinued after 24 h (or 3 doses). LoE 1-GoR A. In these
patients, in the light of the need to reduce infections from
opportunistic microorganisms—such as C. difficile—and
to minimise the evolution of multidrug-resistant bacteria,
such as ESBL, VRE or KPC, prophylactic antibiotics
should be discontinued after 24 h (3 doses) [199].
In 2015, a retrospective review of prospectively collected
data on 143 patients with AL after colorectal cancer
surgery was published [205]. Of the 143 enrolled patients,
46 (32.2%) were classified in the multidrug-resistant
(MDR) group. The use of antibiotics for more than 5 days
before diagnosis of AL and diabetes mellitus were identi-
fied as independent risk factors of MDR acquisition by
multivariate analysis.
Statement 6.3: In patients with colon carcinoma perfor-
ation, antibiotic therapy mainly targeting Gram-negative
bacilli and anaerobic bacteria is always suggested.
Furthermore, in critically ill patients with sepsis early, use of
broader-spectrum antimicrobials is suggested. LoE 1-GoR A
Antimicrobial therapy, typically empiric antibiotic
treatment, plays an important role in the management
of colon cancer perforation. Initial antimicrobial therapy
for patients with IAI is empiric in nature because
patients need immediate treatment and microbiological
data (culture and susceptibility results) usually requires
≥ 24–48 h for the identification of pathogens and
patterns of antibiotic susceptibility [206].
The empirically designed antimicrobial regimen de-
pends on the pathogens presumed to be involved, the
risk factors indicative of major resistance patterns and
the underlying severity of infection.
Considering the intestinal microbiota of the large
bowel, patients with colon cancer perforations require
antibiotic coverage for Gram-negative bacteria, as well
as for anaerobes.
The virulent microorganisms in colorectal proce-
dures are derived from the bowel lumen, where there
are high concentrations of bacteria, such as B. fragilis
and other obligate anaerobes and Enterobacteriaceae
including E. coli [207].
The choice of the antimicrobial regimen poses serious
problems for the management of unstable patients with
sepsis. In these patients, an early and appropriate
empirical antimicrobial therapy has a significant impact
on the outcome [208]. Therefore, in these patients, early
use of broad-spectrum intravenous antimicrobials is al-
ways suggested.
Statement 6.4: In patients with perforated colorectal can-
cer, antibiotic therapy should consider bacterial resistance
and should be refined according to the microbiological
findings, once available. LoE 1-GoR B
The vast majority of colon cancer perforations represent
community-acquired infections. The main resistance threat
in these IAI is posed by extended-spectrum beta-lactamase
(ESBL) producing Enterobacteriaceae, which are becoming
increasingly common in community-acquired infections
worldwide [209].
The results of microbiological testing may have great
importance for the choice of therapeutic strategy of
every patient, in particular in the rationalisation of
targeted antimicrobial treatment [206].
The duration of antibiotic therapy is a matter of debate,
usually ranging from 4 to 7 days according to clinical fea-
tures (source control, fever, leukocytosis, C-reactive pro-
tein, procalcitonin) [207, 210].
Conclusions: grey areas and opportunities for
improvements
We found some limitations within the present
guidelines:
– They fail to cover all the possible abdominal
scenarios when colon cancer occurs as an
emergency: for example, associated resections were
not taken into considerations, neither we discussed
about therapeutic strategies in case of evidence of
peritoneal carcinomatosis.
– Despite our attempts to underline suggestions in
case of low technical resources, the present
guidelines are generally oriented toward hospitals
with high level of resources.
On the other side, in our opinion, the current
guidelines suggest some stimuli for doctors involved
in this field:
– To review the approach to patient suffering from
abdominal pain by introducing and promoting the
use of bedside abdominal US.
– To bear in mind that the emergency surgeon should
have a strong oncologic background or that the
specialised colorectal surgeon should have a strong
background of surgical pathophysiology, emergency
surgery and damage control philosophy.
– To promote the use of clinical pathways within
singular Hospitals.
All the considerations mentioned above, and further
by readers, will be an incentive for further revisions and
improvements.
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Appendix 1
Table 6 Table of statements
Topic No. LoE GoR
1. Diagnosis 1.1 3 B The clinical presentation is variable, except for lower rectal cancer, in which case digital examination could be
diagnostic. Laboratory tests are not specific. Clinical evaluation and laboratory tests have high variability and
low specificity; therefore, the escalation to further diagnostic tools, whenever available, is mandatory.
1.2 3 B (a) In case of clinical suspicion of colon obstruction, computed tomography (CT) scan achieves the confirmation of
diagnosis better than abdominal ultrasound (US), which performs better than abdominal plain X-ray. If CT scan is not
available, a water-soluble colonic contrast enema is a valid alternative in for identifying the site and the nature
of obstruction. (b) In case of clinical suspicion of perforation, abdominal CT scan, which performs better than abdominal
US, should achieve diagnostic confirmation. US performs better than abdominal plain X-ray. LoE 3, GoR B.
1.3 3 B In stable patients, direct visualisation of the site of colonic obstruction should be considered when colonoscopy is
available. In this situation, biopsies should be obtained, especially when the deployment of an endoscopic stent is
planned. LoE 3, GoR B.
1.4 3 B In case of clinical suspicion of perforation, abdominal CT scan, which performs better than abdominal US,
should achieve diagnostic confirmation. US performs better than abdominal plain X-ray.
1.5 3 B There is no specific data regarding staging pathways of CRC presenting as an emergency. CT scan performs better than
US in the abdomen and should be suggested for staging in the suspicion of cancer-related colorectal emergencies. CT
scan of the thorax is not strictly recommended. LoE 3, GoR B
1.6 3 B There is no specific data regarding staging pathways of CRC presenting as emergency. CT scan performs better
than US in the abdomen and should be suggested for staging in the suspicion of cancer-related colorectal
emergencies. CT scan of the thorax is not strictly recommended.
2. Perforation 2.1 2 B When diffuse peritonitis occurs in cancer-related colon perforation, the priority is the control of the sepsis source of
sepsis. Prompt combined medical treatment is advised. LoE 2, GoR B
2.2 3 B Oncologic resection should be performed in order to obtain better oncologic outcomes.
• Perforation at the tumour site: formal resection with or without anastomosis, with or without stoma
• Perforation proximal to tumour site (diastasic): simultaneous tumour resection and management of proximal
perforation is indicated. Depending on the colonic wall conditions, a subtotal colectomy may be required.
The surgeon should consider that only a small proportion of patients undergo reversal of terminal stoma.
3. Left colon
obstruction
3.1 2 B Loop colostomy (C) versus Hartmann’s procedure (HP). Hartmann’s procedure should be preferred to simple
colostomy, since colostomy appears to be associated with longer overall hospital stay and need for multiple
operations, without a reduction in perioperative morbidity LoE 2, GoR B. Loop colostomy should be reserved for
to unresectable tumours (if SEMS is not feasible), for severely ill patients who are too unfit for major surgical
procedures or general anaesthesia.
3.2 3 B Hartmann’s procedure (HP) versus resection and primary anastomosis (RPA)
RPA should be the preferred option for uncomplicated malignant left-sided large bowel obstruction in absence
of other risk factors. Patients with high surgical risk are better managed with HP.
3.3 4 C RPA: the role of diverting stoma
There is no evidence supporting that a covering stoma can reduce the risk of anastomotic leak and its severity.
3.4 2 B Total colectomy versus segmental colectomy. In absence of caecal tears/perforation or, evidence of bowel ischemia or
synchronous right colonic cancers, total colectomy should not be preferred to segmental colectomy, since it does not
reduce morbidity and mortality and is associated with higher rates of impaired bowel function. LoE 2, GoR B.
3.5 2 B Intraoperative colonic irrigation (ICI) versus manual decompression (MD)
ICI and MD are associated with same mortality/morbidity rate. The only significant difference is that MD is a
shorter and simpler procedure. Either procedure could be performed, depending on the experience/preference
of the surgeon.
3.6 4 C RPA: the role of laparoscopy. The role use of laparoscopy in the emergency treatment of OLCC cannot be
recommended and should be reserved to selected favourable cases and in specialised centers.
3.7 4 C Tube decompression (TD)
TD can be a valid alternative option as BTS for high-risk OLCC.
3.8 3 B Palliation: SEMS versus colostomy. In facilities with capability for stent placement, SEMS should be preferred to
colostomy for palliation of OLCC since it is associated with similar mortality/morbidity rates and shorter hospital stay.
LoE 1-GoR A. Alternative treatments to SEMS should be considered in patients eligible for to a bevacizumab-based
therapy. Involvement of the oncologist in the decision is strongly recommended. LoE 3-GoR B
3.9 1 B Bridge to surgery (BTS): SEMS and planned surgery versus emergency surgery
SEMS as bridge to elective surgery offers a better short-term outcome than direct emergency surgery.
The complications are comparable, but the stoma rate is significantly smaller.
Long-term outcomes appear comparable as well, but evidence remains suboptimal; further studies are necessary.
For these reasons, SEMS as BTS cannot be considered the treatment of choice in the management of OLCC,
whilst it may represent a valid option in selected cases and in tertiary referral hospitals.
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Table 6 Table of statements (Continued)
Topic No. LoE GoR
3.10 1 A Extraperitoneal rectal cancer. Locally advanced rectal cancers are better cured treated with a multimodal approach
including neoadjuvant chemoradiotherapy. LoE 1-GoR A. In case of acute obstruction, resection of the primary tumour
should be avoided and a stoma should be fashioned, in order to permit a correct staging and a more appropriate on-
cologic treatment. Transverse colostomy seems to be the best option, but other modalities can be considered. SEMS is
not indicated.
4. Right
occlusion
4.1 2 B In case of right-sided colon cancer causing acute obstruction, right colectomy with primary anastomosis is the preferred
option. A terminal ileostomy associated with colonic fistula represents a valid alternative when if a primary anastomosis
is considered unsafe. LoE 2-GOR B
4.2 2 B For unresectable right-sided colon cancer, a side-to-side anastomosis between the terminal ileum and the transverse
colon (the internal bypass) can be performed; alternatively, a loop ileostomy can be fashioned. Decompressive
caecostomy should be abandoned.
4.3 4 B SEMS as bridge to elective surgery for ORCC is not recommended. It may represent an option in high-risk patients.
4.4 3 B In a palliative setting, SEMS can be an alternative to emergency surgery (ES) in for obstruction due to right colon
cancer obstruction. LoE 3, GOR B
5. Unstable
patients
5.1 2 C A patient with perforation/obstruction due to colorectal cancer should be considered unstable and therefore
amenable for damage control treatment, if at least one of the following items is present:
● pH < 7.2
● Core temperature < 35 °C
● BE < − 8
● Laboratory/clinical evidence of coagulopathy
● Any signs of sepsis/septic shock, including the necessity of inotropic support.
5.2 2 C Damage control should be started as soon as possible, in rapid sequence after resuscitation.
5.3 2 C If the patient is unstable, definitive treatment can be delayed.
Right-sided obstruction:
Right colectomy with terminal ileostomy should be considered the procedure of choice.
Severely unstable patients should be treated with a loop ileostomy.
Right-sided perforation:
Right colectomy with terminal ileostomy should be considered the procedure of choice.
If an open abdomen has to be considered, the stoma creation should be delayed.
Right colectomy with ileo-colic anastomosis could be performed if no significant increase in operative time is
required and good bowel vascularisation is present and expected in the perioperative time.
Left-sided obstruction:
Hartmann’s procedure should be considered the procedure of choice. Severe unstable patients should be treated
with a loop transverse colostomy.
Left-sided perforation:
Hartmann’s procedure should be considered the procedure of choice. If an open abdomen has to be considered,
the stoma creation should be delayed.
5.4 2 C In patient with perforation/obstruction due to colorectal lesions, open abdomen (OA) should be considered if
abdominal compartment syndrome is expected; bowel viability should be reassessed after resection.
There is no clear indication to OA in patients with peritonitis.
OA should be closed within 7 days.
5.5 2 C A close intraoperative communication between surgeon and anesthesiologist is essential to assess the effectiveness
of resuscitation, in order to decide the best treatment option.
6. Antibiotic
therapy
6.1 1 A In patients with colorectal carcinoma obstruction with no systemic signs of infection, antibiotic prophylaxis is
recommended.
6.2 1 A Prophylactic antibiotics should be discontinued after 24 h (or 3 doses).
6.3 1 B In patients with intestinal obstruction, even without systemic signs of infections, antibiotic prophylaxis mainly
targeting Gram-negative bacilli and anaerobic bacteria is suggested, because of the potential ongoing bacterial
translocation.
6.4 1 A In patients with colon carcinoma perforation, antibiotic therapy mainly targeting Gram-negative bacilli and anaerobic
bacteria is always suggested. Furthermore, in critically ill patients with sepsis early, use of broader-spectrum
antimicrobials is suggested.
6.5 1 B In patients with perforated colorectal cancer, antibiotic therapy should consider bacterial resistance,
and should be refined according to the microbiological findings, once available.
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Appendix 2
Appendix 3
Fig. 2 Flowchart for the management of colonic perforation due to colorectal cancer
Fig. 3 Flowchart for the management of colonic obstruction due to colorectal cancer
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